MetaVia (MTVA) Expected to Announce Quarterly Earnings on Thursday

MetaVia (NASDAQ:MTVA) will likely be releasing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.26) per share for the quarter. Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 7:00 AM ET.

MetaVia (NASDAQ:MTVA) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.06. On average, analysts expect MetaVia to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

MetaVia Stock Performance

MTVA stock opened at $0.99 on Thursday. The company has a market capitalization of $23.94 million, a PE ratio of -0.85 and a beta of 0.37. MetaVia has a one year low of $0.56 and a one year high of $2.99. The company’s 50 day moving average price is $0.91 and its two-hundred day moving average price is $0.78.

Analyst Ratings Changes

A number of equities analysts recently commented on MTVA shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of MetaVia in a research report on Wednesday, October 8th. HC Wainwright started coverage on MetaVia in a report on Thursday, September 4th. They issued a “buy” rating and a $12.00 price objective on the stock. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, MetaVia presently has an average rating of “Hold” and a consensus target price of $7.50.

About MetaVia

MetaVia Inc is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc, formerly known as NeuroBo Pharmaceuticals Inc, is based in CAMBRIDGE, Mass.